1-methyl-4-phenyl-2,3-dihydropyridinium has been researched along with benzamide in 1 studies
| Studies (1-methyl-4-phenyl-2,3-dihydropyridinium) | Trials (1-methyl-4-phenyl-2,3-dihydropyridinium) | Recent Studies (post-2010) (1-methyl-4-phenyl-2,3-dihydropyridinium) | Studies (benzamide) | Trials (benzamide) | Recent Studies (post-2010) (benzamide) |
|---|---|---|---|---|---|
| 46 | 0 | 3 | 513 | 2 | 230 |
| Protein | Taxonomy | 1-methyl-4-phenyl-2,3-dihydropyridinium (IC50) | benzamide (IC50) |
|---|---|---|---|
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 5.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cosi, C; Marien, M | 1 |
1 other study(ies) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and benzamide
| Article | Year |
|---|---|
Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Benzamides; Brain Chemistry; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Frontal Lobe; Male; Mesencephalon; Mice; Mice, Inbred C57BL; NAD; Neuroprotective Agents; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteins; Pyridinium Compounds | 1998 |